Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
475 hedge funds and large institutions have $10.3B invested in Exact Sciences in 2019 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 168 increasing their positions, 134 reducing their positions, and 85 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 134
5% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 85
1% more funds holding
Funds holding: 472 → 475 (+3)
1.03% less ownership
Funds ownership: 88.93% → 87.9% (-1%)
24% less capital invested
Capital invested by funds: $13.5B → $10.3B (-$3.25B)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
55% less call options, than puts
Call options by funds: $244M | Put options by funds: $540M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$505M |
| 2 |
Jennison Associates
New York
|
+$242M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$56M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$45M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$43.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$173M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$157M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$123M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$116M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$86.1M |
EXAS Hedge Fund Activity: Q3 2019 in Review
475 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2019, worth a combined $10.3B — down 24% from $13.5B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new EXAS positions and 85 closed out — a net gain of 4 holders — while 168 added to existing stakes and 134 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $505M. The largest seller was Fidelity Investments, cutting an estimated $173M.
- 475 institutional investors held Exact Sciences (EXAS) as of Q3 2019, up from 472 in Q2 2019.
- Funds reported $10.3B of Exact Sciences stock for Q3 2019, down 24% quarter-over-quarter.
- 89 funds opened new Exact Sciences positions in Q3 2019 and 85 closed out, a net change of +4 holders.
- The largest Exact Sciences buyer in Q3 2019 was T. Rowe Price Associates, an estimated $505M added.
- The largest Exact Sciences seller in Q3 2019 was Fidelity Investments, an estimated $173M sold.
Based on aggregated 13F filings for Q3 2019.